Curis (CRIS) Peer Comparison

$1.50

$-0.04 (-2.60%)

As on 27-Aug-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

0.4

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	4	16,614	17,326	13,400	12,305
Revenue ($ Mln)	4	1,054	2,782	2,436	670
Net Profit ($ Mln)	-21.15	755.85	491.50	860.62	-319.95
Net Margin (%)	-490.33	71.69	17.67	35.33	-47.79
RoE (%)	-416.52	--	110.09	42.98	-71.14
Price to Earnings	0.43	19.38	36.49	17.01	--
Price-To-Book	0.81	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	4.31	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	0.07	103.47	1,982.07	85.67	19.14
Gross Profit	9.40	588.53	760.62	2,236.43	829.45
Operating Expenses	40.24	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-35.95	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-21.15	101.11	598.92	1,035.47	-252.08
Provision for Tax	0.00	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-21.15	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	4.70	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	0.60	384.48	187.89	288.55	1,362.63
Current Liabilities	13.68	464.70	1,435.43	361.93	283.35
Total Liabilities	19.97	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	12.25	895.24	1,006.90	1,243.41	440.60
Current Assets	6.72	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	19.97	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	1.04	449.89	120.10	165.93	864.07
Net Current Assets	0.00	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-27.20	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	2.50	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	9.77	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-375.72	-30.01	53.56	32.82	-0.17
ROE (%)	-416.52	163.18	110.09	42.98	-71.14
ROA (%)	-56.94	26.53	15.64	29.32	-16.12
EBIT Margin (%)	-508.41	5.73	21.13	31.04	-0.77
Net Margin (%)	-490.33	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	-0.01	0.00	0.00	0.00	0.00

Growth Ratios

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-62.17	114.85	24.67	9.23	12.22
EBIT Growth (%)	39.95	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	45.65	378.76	17.50	42.89	-115.58
EPS Growth (%)	85.37	353.27	26.84	50.42	-73.87
Book Value Growth (%)	109.92	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-0.10	-59.76	36.06	15.79	-2,869.63
Price / Book Value	0.14	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	0.51	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.22	0.05	0.00	0.00	0.09
Current Ratio	0.49	2.99	0.73	3.46	5.90
Quick Ratio	0.49	2.32	0.73	3.38	5.90
Interest Coverage	-66.37	1.62	--	--	-1.72

Operating Efficiency Ratios

	Curis (CRIS)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	0.00	21.25	15.88	13.74	1.28
Asset Turnover	0.12	0.37	0.89	0.83	0.34
Receivable days	64.77	85.52	50.42	43.48	1.50
Inventory Days	--	1,056.70	--	96.17	--
Payable days	35,047.77	331.01	6.26	147.97	221.81
Cash Conversion Cycle	--	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly